Top Health-care stocks:
Health-care shares were mainly inactive in pre-market trade Thursday.
In health-care stocks news, Navidea Biopharmaceuticals ( NAVB ) said a clinical imaging study showed Karposi's Sarcoma tumor lesions can be visualized and mapped with its Tc 99m tilmanocept, a Manocept platform product.
Shares in the company were trading 6.8% higher at $1.73 during pre-market trading . Over the past 52 weeks, the company has traded between $0.97 and $2.02.
Meanwhile, AmSurg ( AMSG ), a surgery center operator and outsourced physician provider, said its Sheridan unit has acquired Coastal Anesthesiology Consultants, a provider of anesthesia services for Flagler Hospital facilities in the St. Augustine, Florida, market. Financial terms of the deal were not disclosed.
Shares in the company were unchanged at $70.20 during pre-market trading. Over the past 52 weeks, the company has traded between $45.19 and $72.85.
And AcelRx Pharmaceuticals ( ACRX ) said it has published the results of a phase 3 study of its Zalviso drug in Anesthesiology, showing it met the primary endpoint of significantly reducing post operative pain over 48 hours.
Shares in the company were 9.5% higher at $4.50 during pre-market trading. Over the past 52 weeks, the company has traded between $2.96 and $11.65.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.